204 related articles for article (PubMed ID: 10928153)
1. A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data.
Würl P; Lautenschläger C; Meye A; Schmidt H; Bache M; Rath FW; Schönfelder M; Taubert H
Anticancer Res; 2000; 20(3B):2065-72. PubMed ID: 10928153
[TBL] [Abstract][Full Text] [Related]
2. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
Würl P; Meye A; Schmidt H; Lautenschläger C; Kalthoff H; Rath FW; Taubert H
Oncogene; 1998 Mar; 16(9):1183-5. PubMed ID: 9528860
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas.
Würl P; Meye A; Berger D; Bache M; Lautenschläger C; Schmidt H; Kalthoff H; Rath FW; Taubert H
Diagn Mol Pathol; 1997 Oct; 6(5):249-54. PubMed ID: 9458382
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
6. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
Stefanou DG; Nonni AV; Agnantis NJ; Athanassiadou SE; Briassoulis E; Pavlidis N
Anticancer Res; 1998; 18(6B):4673-81. PubMed ID: 9891539
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.
Singer S; Corson JM; Demetri GD; Healey EA; Marcus K; Eberlein TJ
Ann Surg; 1995 Feb; 221(2):185-95. PubMed ID: 7857146
[TBL] [Abstract][Full Text] [Related]
8. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
[TBL] [Abstract][Full Text] [Related]
9. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
[TBL] [Abstract][Full Text] [Related]
11. Expression of P53, MDM2 and Ki-67 antigens in soft tissue sarcomas.
Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
Pol J Pathol; 1999; 50(1):9-16. PubMed ID: 10412269
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas.
Stojadinovic A; Leung DH; Hoos A; Jaques DP; Lewis JJ; Brennan MF
Ann Surg; 2002 Mar; 235(3):424-34. PubMed ID: 11882765
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management.
Heslin MJ; Lewis JJ; Nadler E; Newman E; Woodruff JM; Casper ES; Leung D; Brennan MF
J Clin Oncol; 1997 Aug; 15(8):2832-9. PubMed ID: 9256126
[TBL] [Abstract][Full Text] [Related]
14. [Surgical therapy of abdominal and trunk soft tissue sarcomas].
Schimmack S; Büchler MW; Weitz J
Chirurg; 2009 Mar; 80(3):202-8. PubMed ID: 19221701
[TBL] [Abstract][Full Text] [Related]
15. [Surgical therapy of retroperitoneal soft tissue sarcomas].
Siewert JR; Roder JD; Fink U
Chirurg; 1993 Jul; 64(7):527-34. PubMed ID: 8375202
[No Abstract] [Full Text] [Related]
16. Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas.
Pollino S; Benassi MS; Pazzaglia L; Conti A; Bertani N; Righi A; Piccinni-Leopardi M; Picci P; Perris R
Histol Histopathol; 2018 Jun; 33(6):597-608. PubMed ID: 29297565
[TBL] [Abstract][Full Text] [Related]
17. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications.
Antonescu CR; Leung DH; Dudas M; Ladanyi M; Brennan M; Woodruff JM; Cordon-Cardo C
Am J Pathol; 2000 Mar; 156(3):977-83. PubMed ID: 10702413
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma.
van Dalen T; Hennipman A; Van Coevorden F; Hoekstra HJ; van Geel BN; Slootweg P; Lutter CF; Brennan MF; Singer S
Ann Surg Oncol; 2004 May; 11(5):483-90. PubMed ID: 15078637
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic factors associated with primary retroperitoneal sarcoma.
Qiao MZ; Li CL
Bull Cancer; 2007 Jan; 94(1):E5-7. PubMed ID: 17236999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
